Trial Profile
A Phase 1 Study of Single-dose Subcutaneous E6011 in Japanese Healthy Adult Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2019
Price :
$35
*
At a glance
- Drugs Quetmolimab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Eisai Co Ltd
- 12 Dec 2018 Results published in the Journal of Clinical Pharmacology
- 03 Jun 2014 New trial record